about
The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agentsEarly versus delayed erythropoietin for the anaemia of end-stage kidney diseaseEarly versus delayed erythropoietin for the anaemia of end-stage kidney diseaseSafety of off-label erythropoiesis-stimulating agents for critically ill patientsPhysiology and pharmacology of erythropoietinIron deficiency in gastrointestinal oncologyCardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished dataAntianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry.Erythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis.Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety studyTransfusions and patient burden in chemotherapy-induced anaemia in FranceAn acetate switch regulates stress erythropoiesis.Erythropoietin and cancer: the unintended consequences of anemia correctionHow basic scientists help the pharmaceutical industry market drugs.Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trialErythropoietin and organ protection: lessons from negative clinical trials.Epoetin beta for the treatment of chemotherapy-induced anemia: an update.Pharmacovigilance in oncology: evaluation of current practice and future perspectives.American Society of Nephrology Quiz and Questionnaire 2014: RRT.A Bayesian approach to sequential meta-analysis.Is there any role of intravenous iron for the treatment of anemia in cancer?European Myeloma Network guidelines for the management of multiple myeloma-related complications.Trends in Anemia Management in Hemodialysis Patients with CancerApproach to chemotherapy-associated thrombosis.Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysisEfficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.Pharmacovigilance in practice: erythropoiesis-stimulating agents.Harms of off-label erythropoiesis-stimulating agents for critically ill people.Association of erythropoiesis-stimulating agents and the incidence risk of cancer diagnosis among chronic dialysis patients: a nested case-control study.Risk of venous thromboembolism in cancer patients treated with epoetins or blood transfusions.Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer.Supportive Treatments for Patients with Cancer.Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study.Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients.
P2860
Q24186166-6B87D17B-1D68-4460-BC97-8D6B44A9386DQ24187089-76C8337F-A022-4B89-923D-186DB5BB0A0BQ24194838-4B2931CD-09D6-4E26-9109-1E7D9A41217BQ24200811-7D052642-7339-425C-BDC1-47BBB35F0430Q26866945-46F7E273-2352-4E7A-B3DB-2CBEDCC65B7AQ27023196-DEFA6FB8-A3C4-4418-B2D6-75BAEFC9934EQ30435143-AEA31E64-AC92-425F-ABB1-0B5EB6D8819EQ30803363-C8FE6502-CA21-4D4B-B255-58F68A889461Q31056773-E4B20F16-12D8-433E-8F04-FE24B5A42A47Q33827405-CCC676B0-04E1-4942-A671-2EC630D22C88Q33870071-AA74AE26-D5EC-4399-A94B-3044EC0F251EQ33937375-A12FECDD-9D1E-4A72-85AC-F7346FD2C6A4Q34156703-E016C891-70F8-49D9-A300-ABB8A7A91972Q34488415-9B7E5D1A-08C7-4CA2-841F-0E3F164C1B31Q35047976-34E3DAE6-7611-45FC-A30E-D20000E44D9EQ35079125-510B3EA6-7E32-4006-B3F0-1BDF8C81A76AQ35091635-7F32C1DD-F2A9-41EF-892D-0B54816FEDE5Q35168681-9B7CAAFD-FE8D-4D77-B819-515C9ECF6807Q35183601-221D35DB-6B0C-4EAB-A2A4-426C07E61DEBQ35682147-F984E67D-C2D9-47C0-8C4F-B947C8D7BA46Q36092169-97380789-6BF1-498D-A7E7-7E7343ADDB27Q36108113-FCC8E7BA-1F58-42C4-B67D-90EF8365B2AFQ36115636-CA69BC9A-7481-4801-94C1-DEE408A0B1CBQ36200205-EA97689C-C845-4AF2-8133-4616CE61E6AAQ36304793-A3CF233D-578C-4B75-A913-D1F4CF8CF8E4Q36406741-5DA14D0C-5338-4F6B-9528-D751E8747E56Q36616210-73C5E8BC-BA44-4B85-96C1-0BB84E3DC501Q36619022-D291AAE7-92BD-486D-8DE7-AAA68CE840A2Q37028832-45A875EF-2C2F-4851-BF45-AA3A7988C1D8Q37355597-0DC1BF20-EE0A-4A09-8D66-ABBF23F9B62FQ37577927-8814B739-2356-459D-8E6F-0A0CEB4D9E55Q38217083-536245FA-F770-4A9B-AA24-48FAE6D6962BQ38608377-13C8933A-1FE9-4A25-A647-0AD08F276CBCQ39569552-D177BA8D-5C84-4B6E-A360-761FAEEB6E98Q39749243-0C70C764-3B65-4125-B394-A197020ADD10Q40810746-9FA552ED-35AE-4386-BC50-D6F46B53D1BFQ41270171-A8209850-E902-41F3-9AFA-49F3E435CA98Q42376083-1B38A138-DD57-4D11-9316-B749E63016B2Q43729473-10F41360-5FB4-4036-B0C9-AC1AEE5386EEQ47140896-8CF801E0-B83F-4470-9C17-121BB195D9E0
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Erythropoietin or darbepoetin for patients with cancer
@ast
Erythropoietin or darbepoetin for patients with cancer
@en
Erythropoietin or darbepoetin for patients with cancer
@en-gb
Erythropoietin or darbepoetin for patients with cancer
@nl
type
label
Erythropoietin or darbepoetin for patients with cancer
@ast
Erythropoietin or darbepoetin for patients with cancer
@en
Erythropoietin or darbepoetin for patients with cancer
@en-gb
Erythropoietin or darbepoetin for patients with cancer
@nl
prefLabel
Erythropoietin or darbepoetin for patients with cancer
@ast
Erythropoietin or darbepoetin for patients with cancer
@en
Erythropoietin or darbepoetin for patients with cancer
@en-gb
Erythropoietin or darbepoetin for patients with cancer
@nl
P2093
P2860
P50
P921
P3181
P1476
Erythropoietin or darbepoetin for patients with cancer
@en
P2093
Annette Mettler
Chris Hyde
Jerome Seidenfeld
Nadège Robert
Thomy Tonia
P2860
P3181
P356
10.1002/14651858.CD003407.PUB5
P577
2012-12-12T00:00:00Z